Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INGN Inogen Inc
- Stocks
- Healthcare
- NASDAQ: INGN
Price (delayed)
$6.14
Market cap
$165.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$61.76M
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental
Highlights
Inogen's EPS has soared by 72% YoY and by 24% from the previous quarter
Inogen's net income has soared by 72% YoY and by 23% from the previous quarter
Key stats
What are the main financial stats of INGN
Market
Valuations
Earnings
Shares outstanding
26.89M
Market cap
$165.09M
Enterprise value
$61.76M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.82
Price to sales (P/S)
0.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.18
Revenue
$339.96M
Gross profit
$156.74M
Operating income
-$33.9M
Net income
-$27.48M
EBIT
-$28.02M
EBITDA
-$7.09M
Free cash flow
-$21.13M
Per share
Balance sheet
Liquidity
EPS
-$1.15
EPS diluted
-$1.15
Free cash flow per share
-$0.84
Book value per share
$7.46
Revenue per share
$13.51
TBVPS
$10.61
Total assets
$308.41M
Total liabilities
$110.46M
Debt
$19.21M
Equity
$197.95M
Working capital
$135.26M
Debt to equity
0.1
Current ratio
3.07
Quick ratio
2.43
Net debt/EBITDA
14.57
Margins
Efficiency
Dividend
EBITDA margin
-2.1%
Gross margin
46.1%
Net margin
-8.1%
Operating margin
-10%
Return on assets
-9%
Return on equity
-14.8%
Return on invested capital
-28.5%
Return on capital employed
-11.5%
Return on sales
-8.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INGN stock price
How has the Inogen stock price performed over time
Intraday
-2.54%
1 week
-13.15%
1 month
-16.01%
1 year
-30.39%
YTD
-33.04%
QTD
-13.88%
Financial performance
How have Inogen's revenue and profit performed over time
Revenue
$339.96M
Gross profit
$156.74M
Operating income
-$33.9M
Net income
-$27.48M
Gross margin
46.1%
Net margin
-8.1%
The net margin has soared by 73% year-on-year and by 24% since the previous quarter
Inogen's net income has soared by 72% YoY and by 23% from the previous quarter
The operating margin has soared by 69% YoY and by 21% from the previous quarter
INGN's operating income has surged by 67% year-on-year and by 20% since the previous quarter
Price vs fundamentals
How does INGN's price correlate with its fundamentals
Growth
What is Inogen's growth rate over time
Valuation
What is Inogen stock price valuation
P/E
N/A
P/B
0.82
P/S
0.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.18
Inogen's EPS has soared by 72% YoY and by 24% from the previous quarter
INGN's P/B is 52% below its 5-year quarterly average of 1.7 and 25% below its last 4 quarters average of 1.1
The equity rose by 14% since the previous quarter and by 3.2% year-on-year
The stock's price to sales (P/S) is 72% less than its 5-year quarterly average of 1.6 and 25% less than its last 4 quarters average of 0.6
The revenue has increased by 6% year-on-year
Efficiency
How efficient is Inogen business performance
Inogen's ROS has soared by 73% YoY and by 25% from the previous quarter
Inogen's ROA has soared by 68% YoY and by 23% from the previous quarter
Inogen's return on equity has surged by 66% YoY and by 24% QoQ
INGN's ROIC has soared by 64% YoY and by 20% from the previous quarter
Dividends
What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INGN.
Financial health
How did Inogen financials performed over time
INGN's total assets is 179% greater than its total liabilities
The quick ratio has grown by 27% from the previous quarter and by 12% YoY
The company's current ratio rose by 27% QoQ and by 14% YoY
The debt is 90% smaller than the equity
The debt to equity has decreased by 17% YoY and by 9% from the previous quarter
The equity rose by 14% since the previous quarter and by 3.2% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.